Navigation Links
India's Pharmaceutical Industry to Be Global Player: Study

India's pharmaceutical companies are gearing up to become a major global player, not only in producing low-price generic medicines but also as innovators in drugs and// vaccines, according to a study.

"India is innovating its way out of poverty," said Nature Technology study co-author Peter Singer of the McLaughlin-Rotman Centre for Global Health in Toronto.

India could revolutionise biotechnology on the basis of its large and increasingly well-educated workforce, just as it did information technology, Singer believes.

The costs are considerably lower for companies operating in India, the study published in the April 9 issue of the journal says, citing as an example the way the 1997 launch of an Indian hepatitis B vaccine cut prices to one-thirtieth.

"The biotech industry is globalising rapidly," Singer said, adding that the world market for generics was expected to increase significantly in the next few years as several major drugs lost patent protection.

India is well placed to take advantage of this, according to the study that looked at 21 Indian firms.

The authors caution, however, that the lure of profits on the world market could distract attention from research into illnesses typical of developing countries.

The study was published ahead of a conference in Toronto May 2-4 of biotech firms from the US, Canada, India, China, Brazil and Africa.

Source-IANS/V
'"/>




Page: 1

Related medicine news :

1. Indias anti-AIDS drug market engaged in price war
2. SARS: Indias drugs in demand
3. Indias Hospitals Among The Best, Says Renuka Chowdhury
4. Indias vaccination project gets a boost
5. WHO Commends Indias Bird Flu Response
6. Minister Of State For Industry Urges Corporate Sectors To Help Indias Disabled Population
7. Indias Economic Boom Pack To Waste Children Life
8. Indias Northeast Students to Get Satellite-based Education Soon
9. Norway Grants $80 mn to Indias Health Mission
10. Pakistani Child is Indias Youngest Liver Transplant Recipient
11. Avian flu-free Status to Boost Indias Poultry Exports
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/7/2016)... ... ... A quote from Dr. Edward Hallowell, host of CRN International’s “Distraction” podcast ... glimpse into the mind of those people with ADHD. , Dr. Hallowell, a child ... people with ADHD as having “Ferrari engines for a brain, with bicycle brakes.” , ...
(Date:12/7/2016)... ... December 07, 2016 , ... The Cliff ... located in South Lyon, Dewitt, Williamston, East Lansing, Ann Arbor, and Farmington Hills, ... treatment for a brain tumor. , Jason Bauer and his family are longtime ...
(Date:12/7/2016)... ... December 07, 2016 , ... A. Kevin Spann Insurance, a New York-based firm ... Boroughs, is launching a charity drive to raise funds that will benefit the Marine ... of marines and Navy FMF Corpsmen. Working closely with the MCL, the A. Kevin ...
(Date:12/7/2016)... ... December 07, 2016 , ... Delete® - Tattoo Removal and Laser Salon Offers ... Season. Save Up To 33% Off Botox® and Juvederm® Products Now Through December 31, ... with Delightful Deals on Botox® and Juvederm® just in time for the ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... BOC Business Brilliance Awards under the Best New Product Launch category. Gensuite’s entry ... through user experience. , BOC Global Events & Training Group is a professional ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)... -- According to responses from U.S. oncologists that participated in ... with non-small cell lung cancer (NSCLC), treatment decisions are made ... status. The findings of the survey were presented today as ... ) at the 2016 World Conference on Lung Cancer (WCLC) ... survey results revealed an overall high rate of EGFR mutation ...
(Date:12/7/2016)... ALTO, Calif. , Dec. 7, 2016  Varian ... an update to its previously announced plans to separate ... be executed via a tax-free distribution to Varian stockholders ... stand-alone public company that will hold the Imaging Components ... expected to be executed by the end of January ...
(Date:12/7/2016)... , Dec. 7, 2016 Boehringer ... trial in patients with unresectable malignant pleural mesothelioma ... (PFS). The data, presented at the 17 th ... Vienna , showed nintedanib plus ... placebo plus pemetrexed/cisplatin, with a significantly improved PFS ...
Breaking Medicine Technology: